If you made any changes in Pure these will be visible here soon.

Fingerprint The fingerprint consists of automatically generated concepts related to the associated persons. It is updated automatically, when new content is added.

  • 14 Similar Profiles
Vascular Diseases Medicine & Life Sciences
Niacin Medicine & Life Sciences
LDL Cholesterol Medicine & Life Sciences
Hydroxymethylglutaryl-CoA Reductase Inhibitors Medicine & Life Sciences
Placebos Medicine & Life Sciences
HDL Cholesterol Medicine & Life Sciences
Blood Vessels Medicine & Life Sciences
Cholesterol Ester Transfer Proteins Medicine & Life Sciences

Network Dive into details by clicking on the dots.

Research Output 2014 2019

  • 2 Journal article
  • 1 Conference abstract in journal

Treatment of Hypercholesterolaemia with Pcsk-9-Inhibitors in Denmark. Assessment of Real-Life Data; Extent and Efficacy After the First Years of Clinical Use

Mulverstedt, S., Klausen, I. C., Martinsen, M. H., Kanstrup, H., Thomsen, K. K., Bech, J., Henriksen, F. L., Knold, J., Andersen, L. J., Kobbelgaard, L. H., Theilade, J., Clausen, J., Yafasov, K. M., Egstrup, K., Jensen, J. S. & Heitmann, M., 1 Aug 2019, In : Atherosclerosis. 287, p. E39-E40 EAS19-0731.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

324 Citations (Scopus)

Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease

Bowman, L., Hopewell, J. C., Chen, F., Wallendszus, K., Stevens, W., Collins, R., Wiviott, S. D., Cannon, C. P., Braunwald, E., Sammons, E., Landray, M. J., HPS3/TIMI55–REVEAL Collaborative Group, Schmidt, E. B., Dinesen, P. T., Gammelmark, A., Rix, T. A., Vadmann, H., Andersen, K. P., Christensen, B., Kobbelgaard, L. H. & 3 others, Mikkelsen, B. C., Pedersen, M. S. & Torp-Pedersen, C., 28 Sep 2017, In : The New England Journal of Medicine. 377, 13, p. 1217-1227 11 p.

Research output: Contribution to journalJournal articleResearchpeer-review

Vascular Diseases
LDL Cholesterol
HDL Cholesterol
Cholesterol Ester Transfer Proteins
834 Citations (Scopus)

Effects of extended-release niacin with laropiprant in high-risk patients

Landray, M. J., Haynes, R., Hopewell, J. C., Parish, S., Aung, T., Tomson, J., Wallendszus, K., Craig, M., Jiang, L., Collins, R., Armitage, J. & HPS2-THRIVE Collaborative Group, 17 Jul 2014, In : The New England Journal of Medicine. 371, 3, p. 203-212 10 p.

Research output: Contribution to journalJournal articleResearchpeer-review

Open Access
LDL Cholesterol
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Blood Vessels
Vascular Diseases